Jade Biosciences, Inc. (JBIO) Net income 2020–2025
Jade Biosciences, Inc. (JBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$127.4MFY2025 · since FY2020: -$9.6M → -$127.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$127.4M | -83.0% |
| FY2024 | -$69.6M | +7.8% |
| FY2023 | -$75.5M | -46.6% |
| FY2022 | -$51.5M | -124.3% |
| FY2021 | -$23.0M | -138.9% |
| FY2020 | -$9.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JBIO financial trends
JBIO RevenueJBIO Net marginJBIO Gross profitJBIO Gross marginJBIO Operating incomeJBIO Operating marginJBIO Operating cash flowJBIO Free cash flowJBIO Capital expendituresJBIO Return on equityJBIO Stock buybacksJBIO Dividends paidJBIO Total assetsJBIO Total liabilitiesJBIO Shareholders’ equityJBIO overview →